Genetic Signatures and Microba in Merger Discussions
Filed with ASX · · 2 pages · English
Watch Microba Life Sciences' latest callMicroba Life Sciences (ASX:MAP) Q4 2025 Earnings Call · Replay · Jul 22, 2025Read the transcript of Microba Life Sciences (ASX:MAP) Q4 2025 Earnings CallMicroba Life Sciences Limited on 6ix
Earlier from Microba Life Sciences
- Q4 FY26 Quarterly Investor Presentation & Webinar
- Investor presentation - path to cashflow breakeven
- Pause in Trading
- Q3 FY26 Quarterly Investor Presentation & Webinar
- Appendix 4D & FY26 Interim Report
Later from Microba Life Sciences
- 2026 Annual Report & Appendix 4E
- GSS and MAP agree to Commercial Terms for Merger
- Appointment of Interim Chief Executive Officer
- Microba secures $2m placement and increases cost reductions
- Q1 FY27 Quarterly Activities Report & Appendix 4C
Follow Microba Life Sciences into a list and get an email when it puts out news.
Follow Microba Life Sciences